Technology Partners

Iran Behdasht partners with MicroPort, a global leader in medical technology, known for its high-quality cardiovascular products. MicroPort's innovative solutions include the Firehawk® targeted eluting stent system, which is backed by robust clinical evidence in terms of safety and efficacy. This system sets industry standards for a new generation of cardiac stents, emphasizing their commitment to cutting-edge medical technology. MicroPort's products are internationally approved, meeting stringent global standards, which ensures that healthcare providers and patients in Iran have access to reliable and advanced medical technologies. This partnership underscores our shared commitment to excellence and quality in healthcare.

We have established a collaboration with EverPace to integrate their advanced Navigational Solutions into our medical systems. These solutions offer precise navigation tools designed to enhance interventional procedures, allowing healthcare professionals to perform with greater accuracy and efficiency. By partnering with EverPace, we aim to introduce cutting-edge technologies that will improve treatment outcomes and further advance the quality of care in the healthcare sector in Iran. This partnership reflects our commitment to innovation and our focus on delivering the best medical technologies.

We have initiated a collaboration with Coala Solutions to introduce advanced and intelligent cardiac monitoring technologies in the country. The flagship product, Coala Heart Monitor, leverages artificial intelligence to provide precise and non-invasive monitoring of heart function. This innovative device allows for continuous monitoring of patients' cardiac health, playing a vital role in improving the quality of care. Through this partnership, we aim to enhance cardiac health and deliver more effective healthcare services by integrating cutting-edge technology into our system.

Miethke, a leading expert in neurosurgical implants, is our partner in providing advanced shunt systems for hydrocephalus management. Their products, like the GAV Shunt System and proGAV 2.0, offer precise cerebrospinal fluid regulation, adapting to patient conditions and minimizing complications. This collaboration strengthens our offerings in neurological care solutions. These systems are recognized and approved for their safety and effectiveness, including CE marking, which attests to their compliance with European health, safety, and environmental protection standards. This partnership enhances our ability to deliver high-quality neurological care solutions to our patients.

Sienco is a recognized provider of advanced medical devices, particularly known for its innovative solutions in diagnostics and patient monitoring. The company specializes in creating precision instruments that aid in the accurate measurement and monitoring of patient health metrics. Sienco specializes in heparin anti-coagulation therapy, hypercoagulation assessment, and clinical bleeding management. This partnership allows us to offer innovative diagnostic tools and technologies that enhance the quality of patient care in Iran, ensuring precise and reliable outcomes in critical medical situations.